Delivery Order SPE2DB22D2211-SPE2DB25FSFEZ
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $5,056.95 to AmerisourceBergen Drug Corp for the supply of Terbinafine HCL 250 mg tablets (30-count units). The contract is a firm fixed price delivery order with an ultimate completion date of September 4, 2025, and was awarded on September 3, 2025. This non-set-aside award was competitively awarded, reflecting AmerisourceBergen's demonstrated capability to meet federal pharmaceutical procurement requirements. The place of...
- The Defense Logistics Agency awarded a delivery order valued at $1,381.25 to AmerisourceBergen Drug Corp for the supply of Terbinafine HCL 250 mg tablets in quantities of 30, with an ultimate completion date of August 7, 2025. This is a firm fixed price, non-set-aside contract with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,111.23 to AmerisourceBergen Drug Corp for the supply of Terbinafine HCL 250 mg tablets (100 count) on July 25, 2025, with an ultimate completion date of July 28, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,017.90 to AmerisourceBergen Drug Corp for the supply of Terbinafine HCL 250 mg tablets (30-count). This competitively awarded, firm fixed-price contract was finalized on September 23, 2025, with an ultimate completion date of September 24, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting open competition among...
- The Defense Logistics Agency awarded a delivery order valued at $11,112.30 to AmerisourceBergen Drug Corp for the supply of Terbinafine HCL 250 mg tablets (100-count units) with a completion date of July 31, 2025. This firm fixed-price, non-set-aside contract was awarded on July 30, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as...
- The Defense Logistics Agency awarded a $3,616.95 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Terbinafine HCL 250 mg tablets (30-count units) on September 18, 2025, with completion expected by September 19, 2025. This non-set-aside contract was competitively awarded and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement supporting federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for Terbinafine HCL 250 mg tablets (90-count supply) valued at $4,586.12. This firm fixed-price delivery order, with an ultimate completion date of September 10, 2025, represents a non-competitive set-aside award for pharmaceutical supply to support federal medical procurement needs. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Terbinafine HCL 250 mg tablets (30-count) valued at $2,656.40 under a firm fixed-price contract. This non-set-aside delivery order, awarded on September 16, 2025, represents a single pharmaceutical procurement with an ultimate completion date of September 17, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Terbinafine HCL 250 mg tablets (30-count) on September 15, 2025, with a ceiling value of $42,385.52. This firm fixed-price delivery order, which is expected to be completed by September 16, 2025, represents a routine pharmaceutical procurement supporting federal medical supply needs. The contract was competitively awarded without set-aside provisions, demonstrating AmerisourceBergen's capability to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Terbinafine HCL 250 mg tablets in quantities of 30 tablets, with a ceiling value of $4,397.88. This non-competitive, firm fixed-price delivery order is set to be completed by September 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSFEZDelivery Order
The Defense Logistics Agency awarded a $1,275.23 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Terbinafine HCL 250 mg tablets (30-count supply) on September 17, 2025, with a completion deadline of September 18, 2025. This competitively awarded, non-set-aside contract represents a routine pharmaceutical procurement fulfilled through AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement and maintains a $999.99 billion IDC valued through December 2026, which enables comprehensive pharmaceutical supply support to military healthcare systems globally. AmerisourceBergen Drug Corp's extensive portfolio of federal contracts demonstrates the company's established capability to meet diverse military medical supply requirements through open competition. As a major pharmaceutical distributor and healthcare solutions provider, the company regularly fulfills delivery orders for generic and brand-name medications, vaccines, and specialized medical supplies across multiple therapeutic categories. This award reflects the company's ongoing role in supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through flexible contract vehicles designed to ensure consistent pharmaceutical availability for federal beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 9/17/25 |